Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04374825 · ClinicalTrials.gov registry record · NA
Optimizing Quality of Life in Women Living With Metastatic Breast Cancer
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04374825 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 31 participants.
The verdict
NCT04374825, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and tailor an intervention program to improve the quality of life in women living with metastatic breast cancer. In the first phase of this study, we conducted patient focus groups to gather information about the unique challenges of living with MBC and what kinds of support women would like to receive in a tailored Acceptance and Commitment Therapy (ACT) intervention. In the second phase of the study, we will conduct a three-arm randomized controlled trial to the tailored ACT intervention with both a Cognitive Behavioral Stress Management (CBSM) intervention and usual care. The CBSM and ACT intervention groups will meet with a trained facilitator and 8-9 other patients, once per week via videoconference for 90 minute sessions over the course of 8 weeks.
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy (ACT)
- BEHAVIORAL Cognitive Behavioral Stress Management (CBSM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2019-04-24 |
| Est. Completion | 2021-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04374825
The ClinicalTrials.gov registry entry for NCT04374825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acceptance and Commitment Therapy (ACT) is the first listed.
NCT04374825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04374825 about?
NCT04374825 is a clinical study titled "Optimizing Quality of Life in Women Living With Metastatic Breast Cancer". The purpose of this study is to develop and tailor an intervention program to improve the quality of life in women living with metastatic breast cancer. In the first phase of this study, we conducted patient focus groups to gather information about the unique challenges of living with MBC and what k...
What is the current status of trial NCT04374825?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-04-24. Estimated completion is 2021-03-08.
What interventions are being tested in trial NCT04374825?
The interventions under investigation include: Acceptance and Commitment Therapy (ACT) (BEHAVIORAL), Cognitive Behavioral Stress Management (CBSM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04374825?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.